Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. (NASDAQ:AMGN) Over Humira Biosimilar – FDA Headlines
Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. (NASDAQ:AMGN) Over Humira Biosimilar FDA Headlines Feb 15, 2019 | Business. Coherus Biosciences Inc (NASDAQ:CHRS) Initiates Patent Infringement Battle With Amgen, Inc. Coherus Biosciences Inc …